BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19626672)

  • 1. Nature of "Tau" immunoreactivity in normal myonuclei and inclusion body myositis.
    Salajegheh M; Pinkus JL; Nazareno R; Amato AA; Parker KC; Greenberg SA
    Muscle Nerve; 2009 Oct; 40(4):520-8. PubMed ID: 19626672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies.
    Maurage CA; Bussière T; Sergeant N; Ghesteem A; Figarella-Branger D; Ruchoux MM; Pellissier JF; Delacourte A
    Neuropathol Appl Neurobiol; 2004 Dec; 30(6):624-34. PubMed ID: 15541003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel demonstration of conformationally modified tau in sporadic inclusion-body myositis muscle fibers.
    Nogalska A; D'Agostino C; Engel WK; Askanas V
    Neurosci Lett; 2011 Oct; 503(3):229-33. PubMed ID: 21896314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.
    Askanas V; Engel WK; Bilak M; Alvarez RB; Selkoe DJ
    Am J Pathol; 1994 Jan; 144(1):177-87. PubMed ID: 8291607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
    Mirabella M; Alvarez RB; Bilak M; Engel WK; Askanas V
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):774-86. PubMed ID: 8965093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rimmed vacuoles with beta-amyloid and tau protein deposits in the muscle of children with hereditary myopathy.
    Fidziańska A; Glinka Z
    Acta Neuropathol; 2006 Aug; 112(2):185-93. PubMed ID: 16788822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis.
    Salajegheh M; Pinkus JL; Taylor JP; Amato AA; Nazareno R; Baloh RH; Greenberg SA
    Muscle Nerve; 2009 Jul; 40(1):19-31. PubMed ID: 19533646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis.
    Greenberg SA; Pinkus JL; Amato AA
    Muscle Nerve; 2006 Oct; 34(4):406-16. PubMed ID: 16823856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone H1 is released from myonuclei and present in rimmed vacuoles with DNA in inclusion body myositis.
    Nakano S; Shinde A; Fujita K; Ito H; Kusaka H
    Neuromuscul Disord; 2008 Jan; 18(1):27-33. PubMed ID: 17888663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies.
    De Bleecker JL; De Paepe B; Vervaet VL; Arys B; Creus KK; Werbrouck BF; Martin JJ
    Neuromuscul Disord; 2007 Feb; 17(2):186-93. PubMed ID: 17251024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.
    Pinkus JL; Amato AA; Taylor JP; Greenberg SA
    Neuromuscul Disord; 2014 Jul; 24(7):611-6. PubMed ID: 24857366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation.
    Wilczynski GM; Engel WK; Askanas V
    Am J Pathol; 2000 Jun; 156(6):1835-40. PubMed ID: 10854206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct forms of hyperphosphorylated tau in sporatic versus hereditary inclusion myopathy.
    Rosenblum WI
    J Neuropathol Exp Neurol; 1996 Nov; 55(11):1179-80. PubMed ID: 8939201
    [No Abstract]   [Full Text] [Related]  

  • 14. Three-repeat Tau 69 is a major tau isoform in laser-microdissected Pick bodies.
    Ohkubo T; Sakasegawa Y; Toda H; Kishida H; Arima K; Yamada M; Takahashi H; Mizusawa H; Hachiya NS; Kaneko K
    Amyloid; 2006 Mar; 13(1):1-5. PubMed ID: 16690493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of inclusion body myositis.
    Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase 5 colocalizes with phosphorylated tau in human inclusion-body myositis paired-helical filaments and may play a role in tau phosphorylation.
    Wilczynski GM; Engel WK; Askanas V
    Neurosci Lett; 2000 Oct; 293(1):33-6. PubMed ID: 11065131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion body myositis and paraproteinemia: incidence and immunopathologic correlations.
    Dalakas MC; Illa I; Gallardo E; Juarez C
    Ann Neurol; 1997 Jan; 41(1):100-4. PubMed ID: 9005871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis.
    Kannanayakal TJ; Mendell JR; Kuret J
    Neurosci Lett; 2008 Jan; 431(2):141-5. PubMed ID: 18191026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional gel electrophoresis in inclusion body myositis.
    Hutchinson DO; Jongbloed B
    J Clin Neurosci; 2008 Apr; 15(4):440-4. PubMed ID: 18258434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and therapy of inclusion body myositis.
    Greenberg SA
    Curr Opin Neurol; 2012 Oct; 25(5):630-9. PubMed ID: 22941263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.